Write in a clean editor, then format for Blood Advances in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Blood Advances is a peer-reviewed journal published by Elsevier, covering Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Blood Advances 12 (2023) 45–58.
Formats any DOI in Blood Advances style. No sign-up. |
| Publishes research in | Acute Myeloid Leukemia Research Lymphoma Diagnosis and Treatment CAR-T cell therapy research Hematopoietic Stem Cell Transplantation Chronic Lymphocytic Leukemia Research |
| ISSN | 2473-9529 |
| Citation impact (2-yr) | 5.06 |
| h-index | 130 |
| i10-index | 3,482 |
| Total citations | 155,663 |
| Article processing charge | $3,000 |
| Open access | Yes |
| Top institutions publishing here | Dana-Farber Cancer Institute |
| Journal website | www.sciencedirect.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Abstract In August 2022, these guidelines were reviewed by an expert work group convened by ASH. Review included limited searches for new evidence and discussion of the search results. Following this review, the ASH Committee on Quality agreed to continue monitoring the supporting evidence rather than revise or retire these guidelines at this time. Limited…
BACKGROUND: Despite an increase in the number of therapies available to treat patients with immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist physicians with the management of patients. OBJECTIVE: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in…
Abstract Over the last decade, there have been numerous developments and changes in treatment practices for the management of patients with immune thrombocytopenia (ITP). This article is an update of the International Consensus Report published in 2010. A critical review was performed to identify all relevant articles published between 2009 and 2018. An expert panel…
BACKGROUND: Venous thromboembolism (VTE) is a common complication among patients with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and mortality. OBJECTIVE: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in their decisions about the prevention…
Abstract In October 2022, these guidelines were reviewed by an expert work group convened by ASH. Review included limited searches for new evidence and discussion of the search results. Following this review, the ASH Committee on Quality agreed to continue monitoring the supporting evidence rather than revise or retire these guidelines at this time. Limited…
